ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för sulbactam sodium. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

13 träffar

Bibliografisk träff 2023-12-13

Retracted: Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia.

And Alternative Medicine EC.

Evid Based Complement Alternat Med · retraction of publication; retraction notice · DOI 10.1155/2023/9821412

Bibliografisk träff 2023-11-29

Retracted: The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection.

Methods In Medicine CAM.

Comput Math Methods Med · retraction of publication; retraction notice · DOI 10.1155/2023/9852075

Bibliografisk träff 2023-09-01

Sulbactam Sodium and Durlobactam Sodium.

Författaruppgift saknas

Am J Health Syst Pharm · journal article · DOI 10.1093/ajhp/zxad143

Bibliografisk träff 2023-06-08

Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study.

Zhang R, Gao L, Chen P, Liu W, Huang X, Li X.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2023.1170987

Bibliografisk träff 2022-09-05

Differential Proteomic and Genomic Comparison of Resistance Mechanism of Pseudomonas aeruginosa to Cefoperazone Sodium/Sulbactam Sodium.

Cai S, Zhang K, Wei F, Yang L, Song D, Luo J, Huang H, Gao X, DU G, Kong J, Chen Y.

An Acad Bras Cienc · journal article · DOI 10.1590/0001-3765202220211160

Bibliografisk träff 2022-08-10

Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients.

Zheng L, Jin HB, Guan YY, Yang J.

BMC Pharmacol Toxicol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s40360-022-00603-4

Tillbakadragen publikation 2022-05-31

Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia.

Hu G, Liu W, Wang M.

Evid Based Complement Alternat Med · retracted publication; research-article; journal article · DOI 10.1155/2022/1968020

Bibliografisk träff 2021-10-01

Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients.

Wang XX, Ma CT, Jiang YX, Ge YJ, Liu FY, Xu WG.

World J Clin Cases · research-article; journal article · DOI 10.12998/wjcc.v9.i29.8694

Bibliografisk träff 2021-04-15

Influence of Xuebijing injection combined with cefoperazone sodium and sulbactam sodium in treating hepatitis B-induced liver cirrhosis complicated by spontaneous bacterial peritonitis: TNF-α, IL-18, IL-6, and hepatic function.

Qian D, Zhang Y.

Am J Transl Res · research-article; journal article

Bibliografisk träff 2020-11-01

A case report of rash induced by cefoperazone sodium and sulbactam sodium plus metronidazole sodium chloride combined with morphine hydrochloride.

Huang J, Zhu X, Jiang C, Liu Z.

Ann Palliat Med · journal article; case reports · DOI 10.21037/apm-20-2192

Bibliografisk träff 2016-11-01

Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam.

Qu YJ, Jin SB, Han XC, Zheng LQ.

An Bras Dermatol · journal article; case reports; case-report · DOI 10.1590/abd1806-4841.20165182

Bibliografisk träff 2014-01-17

Ultraviolet spectrophotometry (dual wavelength and chemometric) and high performance liquid chromatography for simultaneous estimation of meropenem and sulbactam sodium in pharmaceutical dosage form.

Marwada KR, Patel JB, Patel NS, Patel BD, Borkhatariya DV, Patel AJ.

Spectrochim Acta A Mol Biomol Spectrosc · journal article · DOI 10.1016/j.saa.2014.01.008

Bibliografisk träff 2011-07-01

[The clinical evaluation of piperacillin and sulbactam sodium in treatment of respiratory, urinary tracts and other infections in 579 patients].

Zhou J, Zhao Y, Guo W, Cao QM, Zhao SM, Li GP, Ma XJ.

Zhonghua Nei Ke Za Zhi · clinical trial; multicenter study; journal article; english abstract

Gå till forskningen.

Publikationer i urvalet

Retracted: Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant <i>Acinetobacter baumannii</i> Pneumonia.

Retracted: The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection.

Sulbactam Sodium and Durlobactam Sodium.

Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study.

Differential Proteomic and Genomic Comparison of Resistance Mechanism of Pseudomonas aeruginosa to Cefoperazone Sodium/Sulbactam Sodium.

Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients.

Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant <i>Acinetobacter baumannii</i> Pneumonia.

Cefoperazone sodium/sulbactam sodium <i>vs</i> piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients.

Influence of Xuebijing injection combined with cefoperazone sodium and sulbactam sodium in treating hepatitis B-induced liver cirrhosis complicated by spontaneous bacterial peritonitis: TNF-α, IL-18, IL-6, and hepatic function.

A case report of rash induced by cefoperazone sodium and sulbactam sodium plus metronidazole sodium chloride combined with morphine hydrochloride.

Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam.

Ultraviolet spectrophotometry (dual wavelength and chemometric) and high performance liquid chromatography for simultaneous estimation of meropenem and sulbactam sodium in pharmaceutical dosage form.

[The clinical evaluation of piperacillin and sulbactam sodium in treatment of respiratory, urinary tracts and other infections in 579 patients].